Gabriel Lopez-Berestein

发表

Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer

Debaditya Chakraborty, Hakan Basagaoglu, Cristina Ivan, 2021, Cancers.

Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.

Robert A Newman, Andrea S Gobin, Gabriel Lopez-Berestein, 2007, International journal of pharmaceutics.

Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia.

Bulent Ozpolat, Sheng Gu, Fadi Abdi, 2004, Blood.

RNA interference in the clinic: challenges and future directions

George A. Calin, Robert L. Coleman, Gabriel Lopez-Berestein, 2011, Nature Reviews Cancer.

Role of Increased n-acetylaspartate Levels in Cancer.

Michele Guindani, Wei Hu, Niki M Zacharias, 2016, Journal of the National Cancer Institute.

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer

George A. Calin, Hui Ling, Priyabrata Mukherjee, 2016, Oncotarget.

Abstract A36: TP53 loss creates therapeutic vulnerability in colorectal cancer

Xiongbin Lu, Xiaoming He, Cristina Ivan, 2017 .

The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression.

Douglas D Boyd, Stanley R Hamilton, Lin Yang, 2008, Cancer research.

Sustained small interfering RNA delivery by mesoporous silicon particles.

Mauro Ferrari, Biana Godin, Ciro Chiappini, 2010, Cancer research.

Nanotechnology in cancer therapy

Bulent Ozpolat, Gabriel Lopez-Berestein, A. Sood, 2013, Journal of drug targeting.

microRNA Therapeutics in Cancer — An Emerging Concept

George A. Calin, Anil K Sood, Gabriel Lopez-Berestein, 2016, EBioMedicine.

Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery

Mauro Ferrari, Xuewu Liu, Haifa Shen, 2013, Clinical Cancer Research.

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Anil K Sood, Robert L Coleman, Gabriel Lopez-Berestein, 2009, Clinical Cancer Research.

Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer

Bulent Ozpolat, Wei Hu, Rajesha Rupaimoole, 2014, Clinical Cancer Research.

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

John L Cleveland, Masaaki Komatsu, Katsuhiko Kitamoto, 2008, Autophagy.

RNAi Therapies: Drugging the Undruggable

George A. Calin, Gabriel Lopez-Berestein, G. Calin, 2014, Science Translational Medicine.

Comprehensive epigenetic analysis of Notch pathway in high-grade serous ovarian cancer

Wei Hu, Cristina Ivan, Robert L. Coleman, 2013 .

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Anil K Sood, Michael T Deavers, Gabriel Lopez-Berestein, 2005, Cancer research.

Notch3 pathway alterations in ovarian cancer.

Jie Huang, Wei Hu, Anil K Sood, 2014, Cancer research.

A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis

Demin Li, Francesca M. Buffa, Roger Patient, 2013, Cancer cell.

Preclinical and clinical development of siRNA-based therapeutics.

Bulent Ozpolat, Anil K Sood, Robert L Coleman, 2015, Advanced drug delivery reviews.

Nanotechnology: Future of Oncotherapy

Anil K Sood, Gabriel Lopez-Berestein, A. Sood, 2015, Clinical Cancer Research.

Erythropoietin Stimulates Tumor Growth via EphB4.

Jie Huang, Bulent Ozpolat, David B Jackson, 2015, Cancer cell.

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.

George A Calin, Rajesha Rupaimoole, Anil K Sood, 2016, Cancer discovery.

Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue

Anil K Sood, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, 2014, Journal of liposome research.

Tumour angiogenesis regulation by the miR-200 family

George A Calin, Rehan Akbani, Prahlad T. Ram, 2013, Nature Communications.

Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer

Anil K Sood, Robert L Coleman, Liz Y. Han, 2006, Cancer biology & therapy.

Liposomal siRNA nanocarriers for cancer therapy.

Bulent Ozpolat, Anil K Sood, Gabriel Lopez-Berestein, 2014, Advanced drug delivery reviews.

Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer

George A. Calin, Gabriel Lopez-Berestein, G. Calin, 2015, Non-coding RNA.

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.

Ilya Shmulevich, Wei Zhang, Matti Nykter, 2013, Cancer cell.

Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.

Jie Huang, Wei Hu, Anil K Sood, 2013, Gynecologic oncology.

Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

Gabriel Lopez-Berestein, M. Hung, A. Tari, 1999, Oncogene.

Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.

Ilya Shmulevich, Yan Sun, Ping Ji, 2015, Journal of the National Cancer Institute.

Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray.

George A Calin, Anil K Sood, Gabriel Lopez-Berestein, 2016, Methods in molecular biology.

Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target.

Ariel Fernández, Gabriel Lopez-Berestein, Ariel Fernández, 2007, Cancer research.

Dicer, Drosha, and outcomes in patients with ovarian cancer.

Jan-Fang Cheng, Len A Pennacchio, Anil K Sood, 2008, The New England journal of medicine.

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

Min Zhang, Prahlad T. Ram, Keith A. Baggerly, 2016, Nature Communications.

Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.

Steven A Curley, Ling Xia, Anil K Sood, 2011, Gastroenterology.

Liposomal siRNA for ovarian cancer.

Anil K Sood, Hee Dong Han, Gabriel Lopez-Berestein, 2009, Methods in molecular biology.